Absci Corp (ABSI)
Healthcare
Biotechnology
7.90 $
+1.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Absci Corp (ABSI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -93 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -6.0 | -11 | -61 | -81 | -65 | -72 | -93 | |
| 0.5 | 1.1 | 6.7 | 13 | 14 | 13 | 12 | |
| 0.0 | 0.4 | 11 | 13 | 11 | 19 | 18 | |
| 0.2 | 1.2 | 2.0 | 12 | – | – | – | |
| -0.1 | 1.0 | -3.1 | -1.5 | 1.5 | -0.4 | 0.4 | |
| 1.1 | 2.2 | 38 | 16 | 0.9 | 0.4 | 1.1 | |
| -1.1 | -2.2 | -67 | -127 | 82 | -42 | -50 | |
| – | – | 210 | – | – | – | – | |
| 2.4 | 1.6 | 123 | 4.6 | -5.3 | -4.0 | -3.2 | |
| 13 | 71 | 336 | 5.2 | -4.5 | 83 | 106 | |
| 5.6 | 58 | 208 | -203 | 13 | -31 | -37 | |
| -7.1 | -13 | -99 | -98 | -65 | -73 | -94 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.